BEGIN:VCALENDAR
VERSION:2.0
PRODID:IEEE vTools.Events//EN
CALSCALE:GREGORIAN
BEGIN:VTIMEZONE
TZID:Canada/Eastern
BEGIN:DAYLIGHT
DTSTART:20220313T030000
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3
TZNAME:EDT
END:DAYLIGHT
BEGIN:STANDARD
DTSTART:20221106T010000
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11
TZNAME:EST
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTAMP:20220601T005116Z
UID:642CB6A7-0792-468D-903C-0714CEAE3DA9
DTSTART;TZID=Canada/Eastern:20220531T103000
DTEND;TZID=Canada/Eastern:20220531T113000
DESCRIPTION:Infrared detectors and imaging systems are becoming increasingl
 y important in a diverse range of astronomic\, military\, and civilian app
 lications. In recent years\, this field has gained significant attention w
 hile incorporating various material combinations and architectures into de
 tector designs with a strong focus on applicability into clinical domains.
  Here\, we will discuss some of our detector structures\, their results\, 
 and our latest work on disease detection. Our study of the biomedical appl
 ication of infrared includes exploration of an Affordable\, Sensitive\, Sp
 ecific\, User-friendly\, Rapid\, Equipment-free\, and Deliverable (ASSURED
 ) diagnostic regimen and testing its clinical feasibility for inflammatory
  bowel diseases (IBDs) and cancer (Breast\, Melanoma\, and Lymphoma) scree
 ning. Our study using Fourier transform infrared (FTIR) spectroscopy in at
 tenuated total reflectance (ATR) sampling mode\, analyzed body fluids in o
 rder to identify reproducible\, stable\, and statistically significant dif
 ferences in spectral signatures of the IR absorbance spectra between the c
 ontrol and disease samples. These results show that serum samples can be u
 sed to detect the biochemical changes induced by these diseases. This tech
 nology can be further developed into a futuristic\, noninvasive\, personal
 ized diagnostic tool for various diseases in which patient-to-patient diff
 erences in molecular signatures would allow the assessment of disease stat
 us and personalized drug management.\n\nSpeaker(s): Prof. Unil Perera\, \n
 \nRoom:MC603\, McConnell Engineering building\, 3480 University Street\, H
 3A 0E9\, Montreal\, Quebec\, Canada\, Virtual: https://events.vtools.ieee.
 org/m/312234
LOCATION:Room:MC603\, McConnell Engineering building\, 3480 University Stre
 et\, H3A 0E9\, Montreal\, Quebec\, Canada\, Virtual: https://events.vtools
 .ieee.org/m/312234
ORGANIZER:odile@ieee.org
SEQUENCE:16
SUMMARY:IEEE Distinguished Lecture - "Infrared detector applications for sa
 fe and healthy living" by Prof. Unil Perera
URL;VALUE=URI:https://events.vtools.ieee.org/m/312234
X-ALT-DESC:Description: <br /><p>Infrared detectors and imaging systems are
  becoming increasingly important in a diverse range of astronomic\, milita
 ry\, and civilian applications. In recent years\, this field has gained si
 gnificant attention while incorporating various material combinations and 
 architectures into detector designs with a strong focus on applicability i
 nto clinical domains. Here\, we will discuss some of our detector structur
 es\, their results\, and our latest work on disease detection.&nbsp\;Our s
 tudy of the biomedical application of infrared includes exploration of an 
 Affordable\,&nbsp\;Sensitive\,&nbsp\;Specific\,&nbsp\;User-friendly\,&nbsp
 \;Rapid\,&nbsp\;Equipment-free\, and&nbsp\;Deliverable (ASSURED) diagnosti
 c regimen and testing its clinical feasibility for inflammatory bowel dise
 ases (IBDs) and cancer (Breast\, Melanoma\, and Lymphoma) screening. Our s
 tudy using Fourier transform infrared (FTIR) spectroscopy in attenuated to
 tal reflectance (ATR) sampling mode\, analyzed&nbsp\; body fluids in order
  to identify reproducible\, &nbsp\;stable\,&nbsp\; and statistically signi
 ficant differences&nbsp\; in spectral signatures of the IR absorbance spec
 tra between the control and disease samples. These results show that serum
  samples can be used to detect the biochemical changes induced by these di
 seases. This technology can be further developed into a futuristic\, nonin
 vasive\, personalized diagnostic tool for various diseases in which patien
 t-to-patient differences in molecular signatures would allow the assessmen
 t of disease status and personalized drug management.</p>
END:VEVENT
END:VCALENDAR